216 related articles for article (PubMed ID: 11734321)
1. Deletion of 16q11 is a recurrent cytogenetic aberration in acute myeloblastic leukemia during disease progression.
Yamamoto K; Nagata K; Kida A; Hamaguchi H
Cancer Genet Cytogenet; 2001 Nov; 131(1):65-8. PubMed ID: 11734321
[TBL] [Abstract][Full Text] [Related]
2. Coexistent t(8;21)(q22;q22) Translocation and 5q Deletion in Acute Myeloid Leukemia.
Yamamoto K; Yakushijin K; Sanada Y; Kawamoto S; Matsuoka H; Minami H
J Clin Exp Hematop; 2015; 55(3):181-5. PubMed ID: 26763368
[TBL] [Abstract][Full Text] [Related]
3. New complex t(2;11;17)(p21;q23;q11), a variant form of t(2;11), associated with del(5)(q23q32) in myelodysplastic syndrome-derived acute myeloblastic leukemia.
Yamamoto K; Nagata K; Morita Y; Inagaki K; Hamaguchi H
Cancer Genet Cytogenet; 2002 Sep; 137(2):119-23. PubMed ID: 12393282
[TBL] [Abstract][Full Text] [Related]
4. AML-associated cytogenetic abnormalities (inv (16), del (16), t(8;21)) in patients with myelodysplastic syndromes.
Estey E; Trujillo JM; Cork A; O'Brien S; Beran M; Kantarjian H; Keating M; Freireich EJ; Stass S
Hematol Pathol; 1992; 6(1):43-8. PubMed ID: 1601822
[TBL] [Abstract][Full Text] [Related]
5. [A case of del(16)(q22) in a patient with acute myeloid leukemia with complex karyotype].
Kim M; Lee JW; Lee JK; Hong YJ; Hong SI; Kang HJ; Cho EH; Chang YH
Korean J Lab Med; 2010 Aug; 30(4):329-33. PubMed ID: 20805702
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.
Tirado CA; Valdez F; Klesse L; Karandikar NJ; Uddin N; Arbini A; Fustino N; Collins R; Patel S; Smart RL; Garcia R; Doolittle J; Chen W
Cancer Genet Cytogenet; 2010 Jul; 200(1):54-9. PubMed ID: 20513535
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related myelodysplastic syndrome/acute myeloid leukemia with del(7)(q22) in a patient with de novo AML.
Kim YG; Cho SY; Park TS; Oh SH; Yoon HJ
Ann Clin Lab Sci; 2011; 41(1):79-83. PubMed ID: 21325260
[TBL] [Abstract][Full Text] [Related]
8. Quantitative acute leukemia cytogenetics.
Mitelman F; Heim S
Genes Chromosomes Cancer; 1992 Jul; 5(1):57-66. PubMed ID: 1384663
[TBL] [Abstract][Full Text] [Related]
9. Monosomy 16 as the sole abnormality in myeloid malignancies.
McGhee EM; Cohen NR; Wolf JL; Ledesma CT; Cotter PD
Cancer Genet Cytogenet; 2000 Apr; 118(2):163-6. PubMed ID: 10748300
[TBL] [Abstract][Full Text] [Related]
10. Novel chromosome 16 abnormality--der(16)del(16) (q13)t(16;21)(p11.2;q22)--associated with acute myeloid leukemia.
Sharma P; Watson N; Robson L; Gallo J; Smith A
Cancer Genet Cytogenet; 1999 Aug; 113(1):25-8. PubMed ID: 10459342
[TBL] [Abstract][Full Text] [Related]
11. Different mechanisms lead to a karyotypically identical t(20;21) in myelodysplastic syndrome and in acute myelocytic leukemia.
Matteucci C; La Starza R; Crescenzi B; Romoli S; Santoro A; Magrin S; Lauria F; Coco FL; Martelli MF; Mecucci C
Cancer Genet Cytogenet; 2003 Jan; 140(1):13-7. PubMed ID: 12550752
[TBL] [Abstract][Full Text] [Related]
12. Trisomy 22 as the sole abnormality is an important marker for the diagnosis of acute myeloid leukemia with inversion 16.
Xu W; Zhou HF; Fan L; Qian SX; Chen LJ; Qiu HR; Zhang SJ; Li JY
Onkologie; 2008 Sep; 31(8-9):440-4. PubMed ID: 18787351
[TBL] [Abstract][Full Text] [Related]
13. Deletion (8)(q22) as the only chromosomal abnormality in a patient with RAEB-t with progression to acute myelocytic leukemia.
Govaerts L; Daenen S; Bong B; Breed A; de Jong B
Cancer Genet Cytogenet; 1988 Feb; 30(2):319-21. PubMed ID: 3422584
[TBL] [Abstract][Full Text] [Related]
14. Duplication of chromosome 1 [dup(1)(q21q32)] as the sole cytogenetic abnormality in a patient previously treated for AML.
Beach DF; Barnoski BL; Aviv H; Patel V; Schwarting R; Strair R; Lachant NA
Cancer Genet; 2012 Dec; 205(12):665-8. PubMed ID: 23168243
[TBL] [Abstract][Full Text] [Related]
15. Translocation (8;12)(q13;p13) during disease progression in acute myelomonocytic leukemia with t(11;19)(q23;p13.1).
Yamamoto K; Nagata K; Tsurukubo Y; Inagaki K; Ono R; Taki T; Hayashi Y; Hamaguchi H
Cancer Genet Cytogenet; 2002 Aug; 137(1):64-7. PubMed ID: 12377416
[TBL] [Abstract][Full Text] [Related]
16. del(2)(p23): a consistent recurrent abnormality in acute myelogenous leukemia.
Verma RS; Macera MJ; da Costa M; Bradley T; Christodoulidou F
Cancer Genet Cytogenet; 1991 Dec; 57(2):175-9. PubMed ID: 1756495
[TBL] [Abstract][Full Text] [Related]
17. Translocation (7;9)(q22;q34) in therapy-related myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloblastic leukemia.
Yamamoto K; Yakushijin K; Kawamori Y; Minagawa K; Katayama Y; Matsui T
Cancer Genet Cytogenet; 2007 Jul; 176(1):61-6. PubMed ID: 17574966
[TBL] [Abstract][Full Text] [Related]
18. Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.
Göhring G; Giagounidis A; Büsche G; Kreipe HH; Zimmermann M; Hellström-Lindberg E; Aul C; Schlegelberger B
Ann Hematol; 2010 Apr; 89(4):365-74. PubMed ID: 19855965
[TBL] [Abstract][Full Text] [Related]
19. Secondary acute myelogenous leukemia (AML) with trisomy 10 and del(9q) following precursor B-cell acute lymphoblastic leukemia (ALL) with a hyperdiploid karyotype.
Al-Tahou K; Jamil S; Mody R; Knaus A; Micale M; Huang J
Cancer Genet; 2012 Oct; 205(10):533-6. PubMed ID: 22944559
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization identifies cryptic t(16;16)(p13;q22) masked by del(16)(q22) in a case of AML-M4 Eo.
Merchant SH; Haines S; Hall B; Hozier J; Viswanatha DS
J Mol Diagn; 2004 Aug; 6(3):271-4. PubMed ID: 15269306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
